Abstract:Abstract Background Recent data pointed that IBD is strictly related to gut microbiota although less is known about the connection between oral microbiota and IBD. It is also known that dysbiosis can lead to oral pathologies. Moreover, microbiome changes under therapeutic agents’ administration for IBD treatment have been described, including the identification of some bacteria as potential predictive markers for treatment effectiveness. The aim of our study was the quantification of salivary Firmicutes and Bacteroidetes in a cohort of IBD patients compared with a control group without IBD. Methods This was a collaborative transversal cohort study between an IBD consultation in a tertiary hospital and a faculty of dental medicine. Patients from IBD consultation were invited to participate and gave their informed consent. The exclusion criteria were the incapacity of mouth opening or give a written informed consent. Demographic and clinical data was collected. Oral health status was accessed to determine the periodontal diagnosis. Unstimulated saliva samples were collected before the oral examination for the quantification by quantitative real-time PCR. Statistical analysis was performed with SPSS 29.0 using Kruskal–Wallis H and Mann-Whitney U tests, and p values ≤ 0.05 were considered statistically significant. Results IBD patients presented an increased abundance of Firmicutes, both for UC (3.4 x10-5) and CD (4.9x10-5) as well as an increased abundance of Bacteroidetes for both UC (1.6 x10-5) and CD (1.4x10-5), when compared to the control group (figure 1). No significant differences were found between different treatments groups or no treatment (table 1) in abundance of Firmicutes and Bacteroidetes, respectively, of UC (p = 0.292 and p = 0.912) and CD (p=0.413 and p=0.254) patients. Additionally, no significant differences were found for Firmicutes and Bacteroidetes abundances, respectively, regarding: CD versus UC (p=0.600 and p=0.971), active disease and remission (based on a composite criterion for inactive disease considering HBI <5 for CD or a PMS ≤ 2 for UC, and FCP cut-off value of 150 mg/Kg), (p= 0.071 and p=0.242), smoking status (p=0.558 and p=0.488) and presence or absence of oral health (p=0.260 and p=0.556). Conclusion The oral microbiota characterization of IBD patients showed an elevated abundance of Firmicutes and Bacteroidetes when compared with healthy controls. These findings are valuable indicators of dysbiosis, emphasizing the intricate interplay between gut and oral microbiome in the context of inflammatory conditions. Future research is needed to clarify the oral-gut microbiome axis in IBD.

Oral bacteria relative abundance in faeces increases due to gut microbiota depletion and is linked with patient outcomes

A High Fraction of Oral Bacteria in the Feces Indicates Gut Microbiota Depletion with Implications for Human Health

The meaning of oral bacteria in faeces

The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease

P1236 Oral microbiota dysbiosis in Inflammatory Bowel Disease patients

Periodontitis may induce gut microbiota dysbiosis via salivary microbiota

Oral, intestinal, and pancreatic microbiomes are correlated and exhibit co-abundance in patients with pancreatic cancer and other gastrointestinal diseases

Disease-associated microbiome signature species in the gut

Oral Microbial Dysbiosis in Patients with Periodontitis and Chronic Obstructive Pulmonary Disease

Can metagenomics unravel the impact of oral bacteriome in human diseases?

Periodontal Inflammation and Dysbiosis Relate to Microbial Changes in the Gut

Insight into the Relationship between Oral Microbiota and the Inflammatory Bowel Disease

The Bacterial Connection between the Oral Cavity and the Gut Diseases

Orally administered pathobionts and commensals have comparable and innocuous systemic effects on germ-free mice

Regulatory effects of oral microbe on intestinal microbiota and the illness

High-throughput sequencing provides insights into oral microbiota dysbiosis in association with inflammatory bowel disease

Effect of Periodontitis and Periodontal Therapy on Oral and Gut Microbiota

Succession of the oral microbiome with the increasing severity of periodontitis

Dysbiosis and Ecotypes of the Salivary Microbiome Associated with Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles.

Periodontitis Salivary Microbiota Worsens Colitis

Microbiome and its relevance to indigenous inflammatory bowel diseases in China